TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Ophthalmic Anti-infective Drug Market, Global Outlook and Forecast 2023-2030

Ophthalmic Anti-infective Drug Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 25 January 2023
  • Pages :63
  • Formats:
  • Report Code:SMR-7543420
OfferClick for best price

Best Price: $2600

Ophthalmic Antiinfective Drug Market Size

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
This report contains market size and forecasts of Ophthalmic Anti-infective Drug in Global, including the following market information:
Global Ophthalmic Anti-infective Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Ophthalmic Anti-infective Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Eyedrops Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Anti-infective Drug include Alcon, AbbVie, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Johnson & Johnson and Thea pharmaceuticals, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Anti-infective Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Anti-infective Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, by Type, 2022 (%)
Eyedrops
Gels
Ointments
Other
Global Ophthalmic Anti-infective Drug Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Ophthalmic Anti-infective Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Anti-infective Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ophthalmic Anti-infective Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Anti-infective Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Anti-infective Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Anti-infective Drug Overall Market Size
2.1 Global Ophthalmic Anti-infective Drug Market Size: 2022 VS 2030
2.2 Global Ophthalmic Anti-infective Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ophthalmic Anti-infective Drug Players in Global Market
3.2 Top Global Ophthalmic Anti-infective Drug Companies Ranked by Revenue
3.3 Global Ophthalmic Anti-infective Drug Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmic Anti-infective Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ophthalmic Anti-infective Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmic Anti-infective Drug Players in Global Market
3.6.1 List of Global Tier 1 Ophthalmic Anti-infective Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Ophthalmic Anti-infective Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Ophthalmic Anti-infective Drug Market Size Markets, 2022 & 2030
4.1.2 Eyedrops
4.1.3 Gels
4.1.4 Ointments
4.1.5 Other
4.2 By Type - Global Ophthalmic Anti-infective Drug Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Anti-infective Drug Revenue, 2018-2023
4.2.2 By Type - Global Ophthalmic Anti-infective Drug Revenue, 2023-2030
4.2.3 By Type - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Anti-infective Drug Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Ophthalmic Anti-infective Drug Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Anti-infective Drug Revenue, 2018-2023
5.2.2 By Application - Global Ophthalmic Anti-infective Drug Revenue, 2023-2030
5.2.3 By Application - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Ophthalmic Anti-infective Drug Market Size, 2022 & 2030
6.2 By Region - Global Ophthalmic Anti-infective Drug Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Anti-infective Drug Revenue, 2018-2023
6.2.2 By Region - Global Ophthalmic Anti-infective Drug Revenue, 2023-2030
6.2.3 By Region - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Ophthalmic Anti-infective Drug Revenue, 2018-2030
6.3.2 US Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.3.3 Canada Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.3.4 Mexico Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Ophthalmic Anti-infective Drug Revenue, 2018-2030
6.4.2 Germany Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4.3 France Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4.4 U.K. Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4.5 Italy Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4.6 Russia Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4.7 Nordic Countries Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.4.8 Benelux Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Ophthalmic Anti-infective Drug Revenue, 2018-2030
6.5.2 China Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.5.3 Japan Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.5.4 South Korea Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.5.5 Southeast Asia Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.5.6 India Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Ophthalmic Anti-infective Drug Revenue, 2018-2030
6.6.2 Brazil Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.6.3 Argentina Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue, 2018-2030
6.7.2 Turkey Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.7.3 Israel Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Ophthalmic Anti-infective Drug Market Size, 2018-2030
6.7.5 UAE Ophthalmic Anti-infective Drug Market Size, 2018-2030
7 Players Profiles
7.1 Alcon
7.1.1 Alcon Corporate Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Ophthalmic Anti-infective Drug Major Product Offerings
7.1.4 Alcon Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.1.5 Alcon Key News
7.2 AbbVie
7.2.1 AbbVie Corporate Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Ophthalmic Anti-infective Drug Major Product Offerings
7.2.4 AbbVie Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.2.5 AbbVie Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Ophthalmic Anti-infective Drug Major Product Offerings
7.3.4 Bausch Health Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.3.5 Bausch Health Key News
7.4 Santen Pharmaceutical
7.4.1 Santen Pharmaceutical Corporate Summary
7.4.2 Santen Pharmaceutical Business Overview
7.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Major Product Offerings
7.4.4 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.4.5 Santen Pharmaceutical Key News
7.5 Lupin Pharmaceuticals
7.5.1 Lupin Pharmaceuticals Corporate Summary
7.5.2 Lupin Pharmaceuticals Business Overview
7.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Major Product Offerings
7.5.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.5.5 Lupin Pharmaceuticals Key News
7.6 Apotex
7.6.1 Apotex Corporate Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Ophthalmic Anti-infective Drug Major Product Offerings
7.6.4 Apotex Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.6.5 Apotex Key News
7.7 Akorn
7.7.1 Akorn Corporate Summary
7.7.2 Akorn Business Overview
7.7.3 Akorn Ophthalmic Anti-infective Drug Major Product Offerings
7.7.4 Akorn Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.7.5 Akorn Key News
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporate Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Major Product Offerings
7.8.4 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News
7.9 Thea pharmaceuticals
7.9.1 Thea pharmaceuticals Corporate Summary
7.9.2 Thea pharmaceuticals Business Overview
7.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Major Product Offerings
7.9.4 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.9.5 Thea pharmaceuticals Key News
7.10 URSAPHARM
7.10.1 URSAPHARM Corporate Summary
7.10.2 URSAPHARM Business Overview
7.10.3 URSAPHARM Ophthalmic Anti-infective Drug Major Product Offerings
7.10.4 URSAPHARM Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.10.5 URSAPHARM Key News
7.11 SIMILASAN
7.11.1 SIMILASAN Corporate Summary
7.11.2 SIMILASAN Business Overview
7.11.3 SIMILASAN Ophthalmic Anti-infective Drug Major Product Offerings
7.11.4 SIMILASAN Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.11.5 SIMILASAN Key News
7.12 Jianfeng Group
7.12.1 Jianfeng Group Corporate Summary
7.12.2 Jianfeng Group Business Overview
7.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Major Product Offerings
7.12.4 Jianfeng Group Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.12.5 Jianfeng Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Ophthalmic Anti-infective Drug Market Opportunities & Trends in Global Market
Table 2. Ophthalmic Anti-infective Drug Market Drivers in Global Market
Table 3. Ophthalmic Anti-infective Drug Market Restraints in Global Market
Table 4. Key Players of Ophthalmic Anti-infective Drug in Global Market
Table 5. Top Ophthalmic Anti-infective Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ophthalmic Anti-infective Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ophthalmic Anti-infective Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ophthalmic Anti-infective Drug Product Type
Table 9. List of Global Tier 1 Ophthalmic Anti-infective Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Anti-infective Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Ophthalmic Anti-infective Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ophthalmic Anti-infective Drug Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2023-2030
Table 30. Alcon Corporate Summary
Table 31. Alcon Ophthalmic Anti-infective Drug Product Offerings
Table 32. Alcon Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Ophthalmic Anti-infective Drug Product Offerings
Table 35. AbbVie Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 36. Bausch Health Corporate Summary
Table 37. Bausch Health Ophthalmic Anti-infective Drug Product Offerings
Table 38. Bausch Health Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 39. Santen Pharmaceutical Corporate Summary
Table 40. Santen Pharmaceutical Ophthalmic Anti-infective Drug Product Offerings
Table 41. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 42. Lupin Pharmaceuticals Corporate Summary
Table 43. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product Offerings
Table 44. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 45. Apotex Corporate Summary
Table 46. Apotex Ophthalmic Anti-infective Drug Product Offerings
Table 47. Apotex Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 48. Akorn Corporate Summary
Table 49. Akorn Ophthalmic Anti-infective Drug Product Offerings
Table 50. Akorn Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson Ophthalmic Anti-infective Drug Product Offerings
Table 53. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 54. Thea pharmaceuticals Corporate Summary
Table 55. Thea pharmaceuticals Ophthalmic Anti-infective Drug Product Offerings
Table 56. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 57. URSAPHARM Corporate Summary
Table 58. URSAPHARM Ophthalmic Anti-infective Drug Product Offerings
Table 59. URSAPHARM Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 60. SIMILASAN Corporate Summary
Table 61. SIMILASAN Ophthalmic Anti-infective Drug Product Offerings
Table 62. SIMILASAN Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
Table 63. Jianfeng Group Corporate Summary
Table 64. Jianfeng Group Ophthalmic Anti-infective Drug Product Offerings
Table 65. Jianfeng Group Ophthalmic Anti-infective Drug Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Ophthalmic Anti-infective Drug Segment by Type in 2022
Figure 2. Ophthalmic Anti-infective Drug Segment by Application in 2022
Figure 3. Global Ophthalmic Anti-infective Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Anti-infective Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ophthalmic Anti-infective Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmic Anti-infective Drug Revenue in 2022
Figure 8. By Type - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 10. By Region - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 11. By Country - North America Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 12. US Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 16. Germany Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 17. France Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 24. China Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 28. India Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 30. Brazil Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2030
Figure 33. Turkey Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2030
Figure 37. Alcon Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. AbbVie Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Bausch Health Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Apotex Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Akorn Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. URSAPHARM Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. SIMILASAN Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jianfeng Group Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount